kmadagan@reedsmith.com

{{ disclaimer.HeaderText }}

{{ disclaimer.BodyCopy }}
Kevin is a health care and FDA regulatory attorney and member of the Life Sciences Health Industry Group. He advises clients across the life sciences and health care spectrum about health care and FDA regulatory issues related to the manufacturing, distribution, and sale of drugs (Rx, OTC, homeopathic), biologics, devices (Rx and OTC), and dietary supplements. His clients include suppliers, manufacturers; repackagers; wholesale and private label distributors; pharmacies (503A, 503B, nuclear); and health care providers.

Notable Quotes

Civic and Charitable Activities

  • Deputy coordinator of the Pro Bono Committee of Reed Smith's Washington, D.C., office 
  • Member of the firmwide Pro Bono Committee
  • Lawyers Committee on Civil Rights

Credentials

  • University of Maryland School of Law, 2006, J.D., Health Law, Journal of Health Care Law & Policy - Manuscripts Editor (2005-2006), Staff Member (2004-2005);
    Maryland Association of Legislative Law Member; Maryland Student Health Law Association Member; Research Assistant in Health Law
  • Virginia Polytechnic Institute, 2000, B.S.

  • Maryland
  • District of Columbia

  • American Bar Association
  • American Health Lawyers Association (AHLA)
  • Food & Drug Law Institute (FDLI)
    • Medical Devices Committee
  • Maryland Bar Association